Flavivirus RNA cap methyltransferase: Structure, function, and inhibition

Frontiers of Biology in China

Volumn 5, Issue 4, 2010, Pages 286-303

  Liu, Lihui ^a   Dong, Hongping ^a,b   Chen, Hui ^a   Zhang, Jing ^a   Ling, Hua ^a   Li, Zhong ^a   Shi, Pei Yong ^a,b   Li, Hongmin ^a,c  

^a WADSWORTH CENTER   (United States)

^b NOVARTIS INSTITUTE FOR TROPICAL DISEASES   (Singapore)

^c STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

Flavivirus NS5; inhibitor; methyltransferase; RNA cap methylation; structure and function

Indexed keywords

FLAVIVIRUS; MUS; WEST NILE VIRUS;

EID: 77956126053     PISSN: 16733509     EISSN: 16733622     Source Type: Journal    
DOI: 10.1007/s11515-010-0660-y     Document Type: Review

References (114)

1. Abraham G, Rhodes D P, Banerjee A K (1975). The 5′ terminal structure of the methylated mRNA synthesized in vitro by vesicular stomatitis virus. Cell, 5(1): 51-58.
2. Ackermann M, Padmanabhan R (2001). De novo synthesis of RNA by the dengue virus RNA-dependent RNA polymerase exhibits temperature dependence at the initiation but not elongation phase. J Biol Chem, 276(43): 39926-39937.
3. Ahola T, Kääriäinen L (1995). Reaction in alphavirus mRNA capping: formation of a covalent complex of nonstructural protein nsP1 with 7-methyl-GMP. Proc Natl Acad Sci U S A, 92(2): 507-511.
4. Arias C F, Preugschat F, Strauss J H (1993). Dengue 2 virus NS2B and NS3 form a stable complex that can cleave NS3 within the helicase domain. Virology, 193(2): 888-899.
5. Asnis D S, Conetta R, Teixeira A A, Waldman G, Sampson B A (2000). The West Nile Virus outbreak of 1999 in New York: the Flushing Hospital experience. Clin Infect Dis, 30(3): 413-418.
6. Asnis D S, Conetta R, Waldman G, Teixeira A A (2001). The West Nile virus encephalitis outbreak in the United States (1999-2000): from Flushing, New York, to beyond its borders. Ann N Y Acad Sci, 951: 161-171.
7. Assenberg R, Ren J, Verma A, Walter T S, Alderton D, Hurrelbrink R J, Fuller S D, Bressanelli S, Owens R J, Stuart D I, Grimes J M (2007). Crystal structure of the Murray Valley encephalitis virus NS5 methyltransferase domain in complex with cap analogues. J Gen Virol, 88(Pt 8): 2228-2236.
8. Barbas C F 3rd, Heine A, Zhong G, Hoffmann T, Gramatikova S, Björnestedt R, List B, Anderson J, Stura E A, Wilson I A, Lerner R A (1997). Immune versus natural selection: antibody aldolases with enzymic rates but broader scope. Science, 278(5346): 2085-2092.
9. Barbosa E, Moss B (1978). mRNA(nucleoside-2′-)-methyltransferase from vaccinia virus. Characteristics and substrate specificity. J Biol Chem, 253(21): 7698-7702.
10. Benarroch D, Egloff M P, Mulard L, Guerreiro C, Romette J L, Canard B (2004). A structural basis for the inhibition of the NS5 dengue virus mRNA 2′-O-methyltransferase domain by ribavirin 5′-triphosphate. J Biol Chem, 279(34): 35638-35643.
11. Bernard K A, Kramer L D (2001). West Nile virus activity in the United States, 2001. Viral Immunol, 14(4): 319-338.
12. Bernard K A, Maffei J G, Jones S A, Kauffman E B, Ebel G, Dupuis A P 2nd, Ngo K A, Nicholas D C, Young D M, Shi P Y, Kulasekera V L, Eidson M, White D J, Stone W B, Kramer L D, and the NY State West Nile Virus Surveillance Team (2001). West Nile virus infection in birds and mosquitoes, New York State, 2000. Emerg Infect Dis, 7(4): 679-685.
13. Bhattacharya D, Hoover S, Falk S P, Weisblum B, Vestling M, Striker R (2008). Phosphorylation of yellow fever virus NS5 alters methyltransferase activity. Virology, 380(2): 276-284.
14. Bisaillon M, Lemay G (1997). Viral and cellular enzymes involved in synthesis of mRNA cap structure. Virology, 236(1): 1-7.
15. Bollati M, Alvarez K, Assenberg R, Baronti C, Canard B, Cook S, Coutard B, Decroly E, de Lamballerie X, Gould E A, Grard G, Grimes J M, Hilgenfeld R, Jansson A M, Malet H, Mancini E J, Mastrangelo E, Mattevi A, Milani M, Moureau G, Neyts J, Owens R J, Ren J, Selisko B, Speroni S, Steuber H, Stuart D I, Unge T, Bolognesi M (2009a). Structure and functionality in flavivirus NSproteins: Perspectives for drug design. Antiviral Res, 2009 Nov 27. [Epub ahead of print] doi: 10. 1016/j. antiviral. 2009. 11. 009.
16. Bollati M, Milani M, Mastrangelo E, de Lamballerie X, Canard B, Bolognesi M (2009b). Crystal structure of a methyltransferase from a no-known-vector Flavivirus. Biochem Biophys Res Commun, 382(1): 200-204.
17. Bollati M, Milani M, Mastrangelo E, Ricagno S, Tedeschi G, Nonnis S, Decroly E, Selisko B, de Lamballerie X, Coutard B, Canard B, Bolognesi M (2009c). Recognition of RNA cap in the Wesselsbron virus NS5 methyltransferase domain: implications for RNA-capping mechanisms in Flavivirus. J Mol Biol, 385(1): 140-152.
18. Brinton M A (1981). Isolation of a replication-efficient mutant of West Nile virus from a persistently infected genetically resistant mouse cell culture. J Virol, 39(2): 413-421.
19. Brinton M A (2002). The molecular biology of West Nile Virus: a new invader of the western hemisphere. Annu Rev Microbiol, 56: 371-402.
20. Brinton M A, Dispoto J H (1988). Sequence and secondary structure analysis of the 5′-terminal region of flavivirus genome RNA. Virology, 162(2): 290-299.
21. Burke D S, Monath T P (2001). Flaviviruses. Philadelphia, PA: Lippincott William & Wilkins.
22. Centers for Disease Control and Prevention (CDC) (2000). Guidelines for surveillance, prevention, and control of West Nile virus infection-United States. MMWR Morb Mortal Wkly Rep, 49(2): 25-28.
23. Chambers T J, Hahn C S, Galler R, Rice C M (1990). Flavivirus genome organization, expression, and replication. Annu Rev Microbiol, 44: 649-688.
24. Chambers T J, Grakoui A, Rice C M (1991). Processing of the yellow fever virus nonstructural polyprotein: a catalytically active NS3 proteinase domain and NS2B are required for cleavages at dibasic sites. J Virol, 65(11): 6042-6050.
25. Chambers T J, Nestorowicz A, Amberg S M, Rice C M (1993). Mutagenesis of the yellow fever virus NS2B protein: effects on proteolytic processing, NS2B-NS3 complex formation, and viral replication. J Virol, 67(11): 6797-6807.
26. Chung K Y, Dong H, Chao A T, Shi P Y, Lescar J, Lim S P (2010). Higher catalytic efficiency of N-7-methylation is responsible for processive N-7 and 2′-O methyltransferase activity in dengue virus. Virology, 402(1): 52-60.
27. Cleaves G R, Dubin D T (1979). Methylation status of intracellular dengue type 2 40 S RNA. Virology, 96(1): 159-165.
28. Cong P, Shuman S (1992). Methyltransferase and subunit association domains of vaccinia virus mRNA capping enzyme. J Biol Chem, 267(23): 16424-16429.
29. Davidson A D (2009). Chapter 2. New insights into flavivirus nonstructural protein 5. Adv Virus Res, 74: 41-101.
30. De la Peña M, Kyrieleis O J, Cusack S (2007). Structural insights into the mechanism and evolution of the vaccinia virus mRNA cap N7 methyl-transferase. EMBO J, 26(23): 4913-4925.
31. Diamond M S, Edgil D, Roberts T G, Lu B, Harris E (2000). Infection of human cells by dengue virus is modulated by different cell types and viral strains. J Virol, 74(17): 7814-7823.
32. Dong H, Ray D, Ren S, Zhang B, Puig-Basagoiti F, Takagi Y, Ho C K, Li H, Shi P Y (2007). Distinct RNA elements confer specificity to flavivirus RNA cap methylation events. J Virol, 81(9): 4412-4421.
33. Dong H, Ren S, Li H, Shi P Y (2008a). Separate molecules of West Nile virus methyltransferase can independently catalyze the N7 and 2′-O methylations of viral RNA cap. Virology, 377(1): 1-6.
34. Dong H, Ren S, Zhang B, Zhou Y, Puig-Basagoiti F, Li H, Shi P Y (2008b). West Nile virus methyltransferase catalyzes two methylations of the viral RNA cap through a substrate-repositioning mechanism. J Virol, 82(9): 4295-4307.
35. Dong H, Zhang B, Shi P Y (2008c). Flavivirus methyltransferase: a novel antiviral target. Antiviral Res, 80(1): 1-10.
36. Egloff M P, Benarroch D, Selisko B, Romette J L, Canard B (2002). An RNA cap (nucleoside-2′-O-)-methyltransferase in the flavivirus RNA polymerase NS5: crystal structure and functional characterization. EMBO J, 21(11): 2757-2768.
37. Egloff M P, Decroly E, Malet H, Selisko B, Benarroch D, Ferron F, Canard B (2007). Structural and functional analysis of methylation and 5′-RNA sequence requirements of short capped RNAs by the methyltransferase domain of dengue virus NS5. J Mol Biol, 372(3): 723-736.
38. Fabrega C, Hausmann S, Shen V, Shuman S, Lima C D (2004). Structure and mechanism of mRNA cap (guanine-N7) methyltransferase. Mol Cell, 13(1): 77-89.
39. Falgout B, Miller R H, Lai C J (1993). Deletion analysis of dengue virus type 4 nonstructural protein NS2B: identification of a domain required for NS2B-NS3 protease activity. J Virol, 67(4): 2034-2042.
40. Fauman E B, Blumenthal R M, Cheng X D (1999) Structure and evolution of AdoMet-dependent methyltransferases. World Scientific Publishing Co., Singapore.
41. Fredericksen B L, Gale M Jr (2006). West Nile virus evades activation of interferon regulatory factor 3 through RIG-I-dependent and -independent pathways without antagonizing host defense signaling. J Virol, 80(6): 2913-2923.
42. Frey P A, Kokesh F C, Westheimer F H (1971). A reporter group at the active site of acetoacetate decarboxylase. I. Ionization constant of the nitrophenol. J Am Chem Soc, 93(26): 7266-7269.
43. Furuichi Y, Shatkin A J (2000). Viral and cellular mRNA capping: past and prospects. Adv Virus Res, 55: 135-184.
44. Geiss B J, Thompson A A, Andrews A J, Sons R L, Gari H H, Keenan S M, Peersen O B (2009). Analysis of flavivirus NS5 methyltransferase cap binding. J Mol Biol, 385(5): 1643-1654.
45. Gong W, O'Gara M, Blumenthal RM, Cheng X (1997). Structure of pvu II DNA-(cytosine N4) methyltransferase, an example of domain permutation and protein fold assignment. Nucleic Acids Res, 25(14): 2702-2715.
46. Gu M, Lima C D (2005). Processing the message: structural insights into capping and decapping mRNA. Curr Opin Struct Biol, 15(1): 99-106.
47. Guyatt K J, Westaway E G, Khromykh A A (2001). Expression and purification of enzymatically active recombinant RNA-dependent RNA polymerase (NS5) of the flavivirus Kunjin. J Virol Methods, 92(1): 37-44.
48. Hager J, Staker B L, Bugl H, Jakob U (2002). Active site in RrmJ, a heat shock-induced methyltransferase. J Biol Chem, 277(44): 41978-41986.
49. Highbarger L A, Gerlt J A, Kenyon G L (1996). Mechanism of the reaction catalyzed by acetoacetate decarboxylase. Importance of lysine 116 in determining the pKa of active-site lysine 115. Biochemistry, 35(1): 41-46.
50. Hodel A E, Gershon P D, Shi X, Quiocho F A (1996). The 1. 85 A structure of vaccinia protein VP39: a bifunctional enzyme that participates in the modification of both mRNA ends. Cell, 85(2): 247-256.
51. Hodel A E, Gershon P D, Quiocho F A (1998). Structural basis for sequence-nonspecific recognition of 5′-capped mRNA by a capmodifying enzyme. Mol Cell, 1(3): 443-447.
52. Hodel A E, Quiocho F A, Gershon P D (1999). VP39-an mRNA capspecific 2′-o-methyltransferase. In: X. D. Cheng and R. M. Blementhal, eds. S-Adenosylmethionine-dependent methyltransferase: structures and functions. 255-282.
53. Hornung V, Ellegast J, Kim S, Brzózka K, Jung A, Kato H, Poeck H, Akira S, Conzelmann K K, Schlee M, Endres S, Hartmann G (2006). 5′-Triphosphate RNA is the ligand for RIG-I. Science, 314(5801): 994-997.
54. Horton J R, Sawada K, Nishibori M, Zhang X, Cheng X (2001). Two polymorphic forms of human histamine methyltransferase: structural, thermal, and kinetic comparisons. Structure, 9(9): 837-849.
55. Issur M, Geiss B J, Bougie I, Picard-Jean F, Despins S, Mayette J, Hobdey S E, Bisaillon M (2009). The flavivirus NS5 protein is a true RNA guanylyltransferase that catalyzes a two-step reaction to form the RNA cap structure. RNA, 15(12): 2340-2350.
56. Jansson A M, Jakobsson E, Johansson P, Lantez V, Coutard B, de Lamballerie X, Unge T, Jones T A (2009). Structure of the methyltransferase domain from the Modoc virus, a flavivirus with no known vector. Acta Crystallogr D Biol Crystallogr, 65(Pt 8): 796-803.
57. Kamer G, Argos P (1984). Primary structural comparison of RNA-dependent polymerases from plant, animal and bacterial viruses. Nucleic Acids Res, 12(18): 7269-7282.
58. Khromykh A A, Kenney M T, Westaway E G (1998). Transcomplementation of flavivirus RNA polymerase gene NS5 by using Kunjin virus replicon-expressing BHK cells. J Virol, 72(9): 7270-7279.
59. Kokesh F C, Westheimer F H (1971). A reporter group at the active site of acetoacetate decarboxylase. II. Ionization constant of the amino group. J Am Chem Soc, 93(26): 7270-7274.
60. Komoto J, Huang Y, Takata Y, Yamada T, Konishi K, Ogawa H, Gomi T, Fujioka M, Takusagawa F (2002). Crystal structure of guanidinoacetate methyltransferase from rat liver: a model structure of protein arginine methyltransferase. J Mol Biol, 320(2): 223-235.
61. Koonin E V (1991). The phylogeny of RNA-dependent RNA polymerases of positive-strand RNA viruses. J Gen Virol, 72(Pt 9): 2197-2206.
62. Koonin E V (1993). Computer-assisted identification of a putative methyltransferase domain in NS5 protein of flaviviruses and lambda 2 protein of reovirus. J Gen Virol, 74(Pt 4): 733-740.
63. Kramer L D, Bernard K A (2001). West Nile virus infection in birds and mammals. Ann N Y Acad Sci, 951: 84-93.
64. Kramer L D, Li J, Shi P Y (2007). West Nile virus. Lancet Neurol, 6(2): 171-181.
65. Kroschewski H, Lim S P, Butcher R E, Yap T L, Lescar J, Wright P J, Vasudevan S G, Davidson A D (2008). Mutagenesis of the dengue virus type 2 NS5 methyltransferase domain. J Biol Chem, 283(28): 19410-19421.
66. Kümmerer B M, Rice C M (2002). Mutations in the yellow fever virus nonstructural protein NS2A selectively block production of infectious particles. J Virol, 76(10): 4773-4784.
67. Kwon T, Chang J H, Kwak E, Lee C W, Joachimiak A, Kim Y C, Lee J, Cho Y (2003). Mechanism of histone lysine methyl transfer revealed by the structure of SET7/9-AdoMet. EMBO J, 22(2): 292-303.
68. Li H, Clum S, You S, Ebner K E, Padmanabhan R (1999). The serine protease and RNA-stimulated nucleoside triphosphatase and RNA helicase functional domains of dengue virus type 2 NS3 converge within a region of 20 amino acids. J Virol, 73(4): 3108-3116.
69. Li J, Wang J T, Whelan S P (2006). A unique strategy for mRNA cap methylation used by vesicular stomatitis virus. Proc Natl Acad Sci U S A, 103(22): 8493-8498.
70. Li L, Lok S M, Yu I M, Zhang Y, Kuhn R J, Chen J, Rossmann M G (2008). The flavivirus precursor membrane-envelope protein complex: structure and maturation. Science, 319(5871): 1830-1834.
71. Lim S P, Wen D, Yap T L, Yan C K, Lescar J, Vasudevan S G (2008). A scintillation proximity assay for dengue virus NS5 2′-O-methyltransferase-kinetic and inhibition analyses. Antiviral Res, 80(3): 360-369.
72. Lindenbach B D, Rice C M (1997). trans-Complementation of yellow fever virus NS1 reveals a role in early RNA replication. J Virol, 71(12): 9608-9617.
73. Lindenbach B D, Rice C M (1999). Genetic interaction of flavivirus nonstructural proteins NS1 and NS4A as a determinant of replicase function. J Virol, 73(6): 4611-4621.
74. Luzhkov V B, Selisko B, Nordqvist A, Peyrane F, Decroly E, Alvarez K, Karlen A, Canard B, Qvist J (2007). Virtual screening and bioassay study of novel inhibitors for dengue virus mRNA cap (nucleoside-2′O)-methyltransferase. Bioorg Med Chem, 15(24): 7795-7802.
75. Malone T, Blumenthal R M, Cheng X (1995). Structure-guided analysis reveals nine sequence motifs conserved among DNA amino-methyltransferases, and suggests a catalytic mechanism for these enzymes. J Mol Biol, 253(4): 618-632.
76. Martin J L, McMillan F M (2002). SAM (dependent) I AM: the S-adenosylmethionine-dependent methyltransferase fold. Curr Opin Struct Biol, 12(6): 783-793.
77. Mastrangelo E, Bollati M, Milani M, Selisko B, Peyrane F, Canard B, Grard G, de Lamballerie X, Bolognesi M (2007). Structural bases for substrate recognition and activity in Meaban virus nucleoside-2′-Omethyltransferase. Protein Sci, 16(6): 1133-1145.
78. Milani M, Mastrangelo E, Bollati M, Selisko B, Decroly E, Bouvet M, Canard B, Bolognesi M (2009). Flaviviral methyltransferase/RNA interaction: structural basis for enzyme inhibition. Antiviral Res, 83(1): 28-34.
79. Moure C M, Bowman B R, Gershon P D, Quiocho F A (2006). Crystal structures of the vaccinia virus polyadenylate polymerase heterodimer: insights into ATP selectivity and processivity. Mol Cell, 22(3): 339-349.
80. Muylaert I R, Chambers T J, Galler R, Rice C M (1996). Mutagenesis of the N-linked glycosylation sites of the yellow fever virus NS1 protein: effects on virus replication and mouse neurovirulence. Virology, 222(1): 159-168.
81. Muylaert I R, Galler R, Rice C M (1997). Genetic analysis of the yellow fever virus NS1 protein: identification of a temperature-sensitive mutation which blocks RNA accumulation. J Virol, 71(1): 291-298.
82. Nicholls A, Sharp K A, Honig B (1991). Protein folding and association: insights from the interfacial and thermodynamic properties of hydrocarbons. Proteins, 11(4): 281-296.
83. Ogino T, Banerjee A K (2007). Unconventional mechanism of mRNA capping by the RNA-dependent RNA polymerase of vesicular stomatitis virus. Mol Cell, 25(1): 85-97.
84. Perera R, Kuhn R J (2008). Structural proteomics of dengue virus. Curr Opin Microbiol, 11(4): 369-377.
85. Petersen L R, Roehrig J T (2001). West Nile virus: a reemerging global pathogen. Emerg Infect Dis, 7(4): 611-614.
86. Peyrane F, Selisko B, Decroly E, Vasseur J J, Benarroch D, Canard B, Alvarez K (2007). High-yield production of short GpppA- and 7MeGpppA-capped RNAs and HPLC-monitoring of methyltransfer reactions at the guanine-N7 and adenosine-2′O positions. Nucleic Acids Res, 35(4): e26.
87. Podvinec M, Lim S P, Schmidt T, Scarsi M, Wen D, Sonntag L S, Sanschagrin P, Shenkin P S, Schwede T (2010). Novel inhibitors of dengue virus methyltransferase: discovery by in vitro-driven virtual screening on a desktop computer grid. JMed Chem, 53(4): 1483-1495.
88. Puig-Basagoiti F, Qing M, Dong H, Zhang B, Zou G, Yuan Z, Shi P Y (2009). Identification and characterization of inhibitors of West Nile virus. Antiviral Res, 83(1): 71-79.
89. Ray D, Shah A, Tilgner M, Guo Y, Zhao Y, Dong H, Deas T S, Zhou Y, Li H, Shi P Y (2006). West Nile virus 5′-cap structure is formed by sequential guanine N-7 and ribose 2′-O methylations by nonstructural protein 5. J Virol, 80(17): 8362-8370.
90. Reinisch K M, Nibert M L, Harrison S C (2000). Structure of the reovirus core at 3. 6 A resolution. Nature, 404(6781): 960-967.
91. Rice C M, Lenches E M, Eddy S R, Shin S J, Sheets R L, Strauss J H (1985). Nucleotide sequence of yellow fever virus: implications for flavivirus gene expression and evolution. Science, 229(4715): 726-733.
92. Sampath A, Padmanabhan R (2009). Molecular targets for flavivirus drug discovery. Antiviral Res, 81(1): 6-15.
93. Schnierle B S, Gershon P D, Moss B (1994). Mutational analysis of a multifunctional protein, with mRNA 5′ cap-specific (nucleoside-2′-O-)-methyltransferase and 3′-adenylyltransferase stimulatory activities, encoded by vaccinia virus. J Biol Chem, 269(32): 20700-20706.
94. Selisko B, Peyrane F F, Canard B, Alvarez K, Decroly E (2010). Biochemical characterization of the (nucleoside-2′O)-methyltransferase activity of dengue virus protein NS5 using purified capped RNA oligonucleotides (7Me)GpppAC(n) and GpppAC(n). J Gen Virol, 91(Pt 1): 112-121.
95. Shi P Y, Kauffman E B, Ren P, Felton A, Tai J H, Dupuis A P 2nd, Jones S A, Ngo K A, Nicholas D C, Maffei J, Ebel G D, Bernard K A, Kramer L D (2001). High-throughput detection of West Nile virus RNA. J Clin Microbiol, 39(4): 1264-1271.
96. Shi P Y, Tilgner M, Lo M K (2002a). Construction and characterization of subgenomic replicons of New York strain of West Nile virus. Virology, 296(2): 219-233.
97. Shi P Y, Tilgner M, Lo MK, Kent K A, Bernard K A (2002b). Infectious cDNA clone of the epidemic west nile virus from New York City. J Virol, 76(12): 5847-5856.
98. Shiryaev S A, Ratnikov B I, Chekanov A V, Sikora S, Rozanov D V, Godzik A, Wang J, Smith J W, Huang Z, Lindberg I, Samuel M A, Diamond M S, Strongin A Y (2006). Cleavage targets and the D-arginine-based inhibitors of the West Nile virus NS3 processing proteinase. Biochem J, 393(Pt 2): 503-511.
99. Shuman S (2001). Structure, mechanism, and evolution of the mRNA capping apparatus. Prog Nucleic Acid Res Mol Biol, 66: 1-40.
100. Smithburn B C, Hughes T P, Burke AW, Paul J H (1940). A neurotropic virus isolated from the blood of a native Uganda. Am J Trop Med Hyg, 20: 471-492.
101. Sutton G, Grimes JM, Stuart D I, Roy P (2007). Bluetongue virus VP4 is an RNA-capping assembly line. Nat Struct Mol Biol, 14(5): 449-451.
102. Tan B H, Fu J, Sugrue R J, Yap E H, Chan Y C, Tan Y H (1996). Recombinant dengue type 1 virus NS5 protein expressed in Escherichia coli exhibits RNA-dependent RNA polymerase activity. Virology, 216(2): 317-325.
103. Warrener P, Tamura J K, Collett M S (1993). RNA-stimulated NTPase activity associated with yellow fever virus NS3 protein expressed in bacteria. J Virol, 67(2): 989-996.
104. Wengler G, Wengler G (1981). Terminal sequences of the genome and replicative-from RNA of the flavivirus West Nile virus: absence of poly(A) and possible role in RNA replication. Virology, 113(2): 544-555.
105. Wengler G, Wengler G (1991). The carboxy-terminal part of the NS 3 protein of theWest Nile flavivirus can be isolated as a soluble protein after proteolytic cleavage and represents an RNA-stimulated NTPase. Virology, 184(2): 707-715.
106. Westaway E G, Brinton MA, Gaidamovich S Y, Horzinek MC, Igarashi A, Kaariainen L, Lvov D K, Porterfield J S, Russell P K, Trent D W (1985). Flaviviridae Intervirol, 24: 183-192.
107. WHO (2009a). Dengue factsheet. http://www. who. int/mediacentre/factsheets/fs117/en/.
108. WHO (2009b). Immunization, vaccines and biologicals: Japanese encephalitis. http://www. who. int/nuvi/je/en/.
109. WHO (2009c). Yellow fever factsheet. http://www. who. int/mediacentre/factsheets/fs100/en/.
110. Yu I M, Zhang W, Holdaway H A, Li L, Kostyuchenko V A, Chipman P R, Kuhn R J, Rossmann M G, Chen J (2008). Structure of the immature dengue virus at low pH primes proteolytic maturation. Science, 319(5871): 1834-1837.
111. Zhang X, Zhou L, Cheng X (2000). Crystal structure of the conserved core of protein arginine methyltransferase PRMT3. EMBO J, 19(14): 3509-3519.
112. Zhou Y, Ray D, Zhao Y, Dong H, Ren S, Li Z, Guo Y, Bernard K A, Shi P Y, Li H (2007). Structure and function of flavivirus NS5 methyltransferase. J Virol, 81(8): 3891-3903.
113. Zubieta C, He X Z, Dixon R A, Noel J P (2001). Structures of two natural product methyltransferases reveal the basis for substrate specificity in plant O-methyltransferases. Nat Struct Biol, 8(3): 271-279.
114. Zuker M (2003). Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res, 31(13): 3406-3415.